LifeMD reports FY2021 preliminary revenue of $92.9M, +149% YoY; FY2022 guidance $142-148M

LifeMD, Inc.

Preliminary Q4 2021 revenue $27.4M; FY2021 revenue $92.9M (149% YoY growth).
FY2022 revenue guidance $142-148M; Adj. EBITDA loss guidance ($14M)-($20M).
Q1 2022 revenue guidance $30-32M; Adj. EBITDA loss ($6.5M)-($7.5M).
Reaffirms Adj. EBITDA profitability target by Q4 2022.
Company highlights acquisition of Cleared and launch of LifeMD Virtual Primary Care Platform.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.